Syringes Market Report Scope & Overview:

The Syringes Market was valued at USD 17.00 billion in 2025E and is expected to reach USD 33.08 billion by 2033, growing at a CAGR of 8.68% over the forecast period of 2026-2033. 

The global syringes market is growing at a solid pace on account of high regulatory and safety standards. Health agencies have been urging the use of auto-disable, safety, and single-use syringes to prevent cross-contamination and needle-stick injuries. Furthermore, the increasing use of biologic therapeutics in oncology and autoimmune diseases is driving demand for prefilled and specialty syringes, signalling a substantial change compared to past syringes market trends.

For instance, in January 2025, the WHO reported that 85% of LMICs adopted auto-disable syringes for immunization, targeting 100% compliance by 2026 to enhance injection safety.

Syringes Market Size and Forecast

• Syringes Market Size in 2025: USD 17.00 Billion

• Syringes Market Size by 2033: USD 33.08 Billion

• CAGR: 8.68% from 2026 to 2033

• Base Year: 2025E

• Forecast Period: 2026–2033

• Historical Data: 2022–2024

To Get more information on Syringes Market - Request Free Sample Report

Syringes Market Trends

• Rising demand for vaccines, biologics, and injectable drugs is driving the syringes market.

• Growing adoption of safety-engineered and auto-disable syringes is boosting market growth.

• Expansion of immunization programs and increasing global vaccination coverage are fueling demand.

• Advancements in needle-free and prefilled syringe technologies are enhancing patient compliance and safety.

• Increasing prevalence of chronic diseases requiring injectable therapies is shaping market trends.

• Rising awareness of infection control and healthcare safety standards is influencing product adoption.

• Collaborations between syringe manufacturers, pharmaceutical companies, and healthcare providers are accelerating innovation and market expansion.

The U.S. syringes market was valued at USD 5.81 billion in 2025E and is expected to reach USD 11.24 billion by 2033, growing at a CAGR of 8.60% over 2026-2033.

The U.S occupies the largest market share for syringes owing to the early introduction of safety-engineered syringes, prompted by OSHA and FDA regulations working toward reducing needlestick injuries. Also, the support of liberal financial reimbursements by Medicare, Medicaid, and private insurers facilitates broad accessibility to injectable therapies.

Syringes Market Growth Drivers:

• Growth in Biologic Drugs is Driving the Syringes Market Growth

Rising use of biologics, including in the treatment of autoimmune diseases and cancer, is a major driver of the demand for prefilled and specialty syringes, since these types of drugs demand exact, sterile dosing. This is further driving the syringes market share in the pharmaceutical sector, particularly in developed regions where biologics play an important role in chronic disease and self-injection therapies are gaining popularity.

For instance, in March 2025, IQVIA reported that biologics made up 35% of global drug spending, with 60% administered via syringes, boosting the syringes market share significantly.

Syringes Market Restraints:

• Needle-Stick Injury Concerns Are a Significant Restraint on the Syringes Market Growth

The syringes market growth is hindered by factors including concerns about needle-stick injuries, non-sterile administered agents, inadequate waste disposal, and the high price of safety-engineered syringes in low-income countries. The demand for AD syringes is facing challenges, including severe regulation, restricted availability of next-generation syringes in rural sectors, and the increasing acceptance of needle-free drug delivery systems, which can impede market growth.

Syringes Market Opportunities:

• Biologics & Biosimilars Growth Drive Future Growth Opportunities for the Syringes Market

The rapid growth of biologics and biosimilars for cancer, autoimmune, and rare diseases generates a need for dedicated syringes. Pre-filled and safety syringes are necessary for the safe and accurate injection of high-viscosity drugs. This trend presents opportunities for manufacturers to develop tailored innovations that improve the dose accuracy, patient comfort, and adherence that are critical to the successful delivery of biologic treatments.

For instance, in April 2025, over 60% of late-stage biologics in development are intended for injectable delivery, with prefilled and safety syringes dominating global administration trends.

Syringes Market Segment Highlights

• By usage, disposable syringes held the largest share of around 48.94%, and the reusable syringes segment is expected to register the highest growth

• By application, the vaccines and immunizations segment dominated the market with approximately 40.80%share, while the diabetes segment is expected to register the highest growth

• By material, plastic syringes accounted for the leading share of nearly 60.14%, and are expected to register the highest growth

• By end user, the direct tenders led the market with about 45.86% share, and online pharmacies are forecasted to grow the fastest at a CAGR

Syringes Market Segment Analysis

By Usage, Disposable Syringes lead the Market, While Reusable Syringes Register the Fastest Growth

The disposable syringes segment accounted for the highest revenue share of approximately 68.94%in 2025, owing to their low technology costs, single-use safety, and their frequent usage in vaccination, therapeutic, and diagnostic applications. They help to prevent cross-contamination and are widely used in mass vaccination efforts globally.

In comparison, the reusable syringes segment is anticipated to achieve the highest CAGR of nearly 9.11% during the 2026–2033 period, driven by their affordability, sustainability, and growing use of veterinary and low-resource applications. Space and weight savings are resulting in quicker utilization due to improved sterilizable materials.

By Application, The Vaccines and Immunizations Segment Dominates, While the Diabetes Segment Shows Rapid Growth

The vaccines and immunizations segment held the largest revenue share of approximately 40.80% in 2025, as a result of widespread global vaccination campaigns for diseases including COVID-19, influenza, and HPV. Safe injection and infection control are ensured by widespread use of auto-disable and disposable syringes.

On the other hand, the diabetes segment is predicted to grow at the strongest CAGR of approximately 9.47% during 2025–2032, fueled by the increasing prevalence of global type 1 and type 2 diabetes, particularly among the elderly and the obese. Increased dependence on insulin treatment, rising trend for self-administration.

By Material, Plastic Syringes, Lead, and Registers Fastest Growth

Plastic Syringes accounted for the largest share of the syringes market with about 60.14%, driven by their low price, disposability, small size, and wide use in vaccination and immunization programs. Due to their compatibility with auto-disable and safety features, relative ease of mass production, and universal availability, they are potential candidates for public health interventions. In addition, it is slated to grow at the fastest rate with a CAGR of around 8.90% throughout the forecast period of 2026–2033, its cost-efficiency, light weight, and simple mass production characteristics. They minimize the risk of breakage over glass and are available in single-pack disposable or refillable designs, and are compliant with global safety standards.

By End User, Direct Tenders Lead, And Online Pharmacies Grow the Fastest

The Direct Tenders held the largest revenue share of around 45.86% in the syringes market in 2025, as governments and global health organizations buy high syringe volumes directly over manufacturers for vaccination and public health campaigns. These guarantees optimum cost and security of supply and quality control.

The online pharmacies segment, however, is projected to register the highest CAGR of around 9.51% during the forecast period of 2026-2033, fuelled by the increased e-commerce adoption, the convenience of home delivery, and more chronic diseases being managed at home.

Syringes Market Regional Analysis

North America Syringes Market Insights

North America accounted for the highest revenue share of approximately 42.60% in 2025 of the Syringes Market, owing to its medical infrastructure, high vaccination rates, and high number of people with chronic conditions, including diabetes and cancer. Increased multiple solid government initiatives, including the CDC vaccination initiative and OSHA and FDA safety regulations, support steady demand. Furthermore, the participation of numerous stakeholders and the usage of disposable and safety syringes drive regional dominance.

Get Customized Report as per Your Business Requirement - Enquiry Now

Asia Pacific Syringes Market Insights

Asia-Pacific emerges as the fastest-growing region with the highest CAGR of 9.45%, owing to the high urbanization, growing healthcare spending, and increasing government-run immunization programs, including in India, China, and Indonesia, which are driving the demand for syringes at an incredible pace. The increasing prevalence of chronic diseases, including diabetes, cancer, along with an increasing geriatric population, is further boosting market adoption.

Europe Syringes Market Insights

Europe is the second leading player in the syringes market, driven by the universal healthcare systems, healthy vaccination programs, and a large number of cases of age-related and chronic diseases. Immunization campaigns and a focus on safe injection and good pharmaceutical infrastructure have enhanced demand. Increasing knowledge about infection control and ongoing technological development by European syringe manufacturers is also contributing to the large market share of the region in terms of syringes for public and private healthcare providers.

Latin America (LATAM) and Middle East & Africa (MEA) Syringes Market Insights

The syringes market in Latin America and the Middle East & Africa is growing on account of growth in vaccination programs, prevalence of chronic diseases, and government initiatives towards safe injection. Rapidly increasing healthcare infrastructure, public health awareness, and collaborations with international bodies, including the WHO and UNICEF, also contribute to this demand, where prefilled and safety syringes see large-scale penetration.

Competitive Landscape for the Syringes Market:

BD (Becton, Dickinson and Company)

BD is a leading global medical technology company specializing in medical devices, instrument systems, and reagents. The company focuses on advancing medication delivery, biosciences, and patient-safety solutions, with innovations in syringes, infusion systems, and diagnostics. BD emphasizes precision, reliability, and global healthcare access, supporting hospitals, vaccination programs, and biologics administration while aligning with sustainability and emerging-market growth initiatives.

• March 2025: Launched advanced prefilled syringes with reduced dead space, enhancing biologics delivery, patient safety, and dosing accuracy globally, targeting hospitals, vaccination programs, and high-demand emerging markets.

B. Braun Melsungen AG

B. Braun is a multinational healthcare company providing medical devices, pharmaceutical solutions, and hospital services. It prioritizes patient safety, sustainability, and innovation in medication delivery, infusion therapy, and biologics administration. The company focuses on eco-friendly and high-precision solutions, supporting hospitals, clinics, and vaccination initiatives worldwide while addressing environmental responsibility and operational efficiency in healthcare systems.

• January 2025: Introduced eco-friendly, biodegradable syringes in Europe, minimizing medical waste, maintaining dosing accuracy, and supporting sustainability initiatives across hospitals, vaccination campaigns, and biologics delivery.

Terumo Corporation

Terumo Corporation is a global medical device leader specializing in vascular intervention, cardiovascular systems, and medical consumables. The company focuses on innovative syringe and injection technologies, biologics delivery, and chronic-disease management solutions. Terumo emphasizes reliability, precision, and scalability, supporting healthcare providers in emerging markets, vaccination campaigns, and growing patient populations while ensuring compliance with global quality and safety standards.

• October 2024: Expanded production facilities in India to meet rising demand for insulin and biologics syringes, strengthening supply for emerging markets and supporting chronic disease and vaccination programs.

Syringes Market Key Players

Some of the Syringes Market companies are:

• Becton, Dickinson and Company

• B. Braun Melsungen AG

• Terumo Corporation

• Nipro Corporation

• Smiths Medical

• Medtronic plc

• Cardinal Health, Inc.

• Hindustan Syringes & Medical Devices

• Gerresheimer AG

• SCHOTT AG

• Weigao Group

• Retractable Technologies, Inc

• Vigmed AB

• OMPI 

• Baxter International Inc.

• Ypsomed Holding AG

• JMI Syringes & Medical Devices Ltd.

• Roselabs Bioscience Ltd.

• Poly Medicure Ltd.

• Narang Medical Limited